Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
04 2021
Historique:
received: 02 06 2020
revised: 05 11 2020
accepted: 09 11 2020
pubmed: 21 12 2020
medline: 28 8 2021
entrez: 20 12 2020
Statut: ppublish

Résumé

The objective of the present study was to use cardiovascular magnetic resonance (CMR) to examine the natural history of secondary MR severity and the implication of left ventricular (LV) scar on its prognostic significance. There is a need for further understanding of the prognostic implication of secondary mitral regurgitation (MR) given the heterogeneous findings of the 2 recent randomized trials on percutaneous mitral intervention in patients with secondary MR. Patients with heart failure were enrolled into a prospective observational registry between 2008 and 2019. Outcomes were a composite of all-cause death, heart transplantation, or LV assist device implantation at follow-up. CMR was used to quantify the mitral regurgitation volume and mitral regurgitation fraction (MRF) along with scar burden utilizing late gadolinium enhancement. Patients were categorized into 4 subgroups based on presence and tertiles of scar extent: no scar, limited scar (scar burden 1% to 4%), intermediate scar (scar burden 5% to 20%), and extensive scar (scar burden >20%). Among patients (n = 441) included in the study (age 59 ± 14 years, 43% with ischemic etiology), 85 (19%) experienced an adverse event. MRF ≥30% was associated with increased risk of events among the study group (hazard ratio: 1.74; 95% confidence interval: 1.10 to 2.76; p = 0.02). When stratified by presence or absence of scar, MRF ≥30% was associated with events only among patients with scar (hazard ratio: 1.67; 95% confidence interval: 1.02 to 2.76; p = 0.04) but not among patients without scar. On further classification of patients with scar, the prognostic significance of secondary MR was observed primarily among patients with intermediate scar burden. The natural history of secondary MR is complex, and outcomes are affected by severity of MR and vary depending upon the extent of scar. (DeBakey Cardiovascular Magnetic Resonance Study [DEBAKEY-CMR]; NCT04281823).

Sections du résumé

OBJECTIVES
The objective of the present study was to use cardiovascular magnetic resonance (CMR) to examine the natural history of secondary MR severity and the implication of left ventricular (LV) scar on its prognostic significance.
BACKGROUND
There is a need for further understanding of the prognostic implication of secondary mitral regurgitation (MR) given the heterogeneous findings of the 2 recent randomized trials on percutaneous mitral intervention in patients with secondary MR.
METHODS
Patients with heart failure were enrolled into a prospective observational registry between 2008 and 2019. Outcomes were a composite of all-cause death, heart transplantation, or LV assist device implantation at follow-up. CMR was used to quantify the mitral regurgitation volume and mitral regurgitation fraction (MRF) along with scar burden utilizing late gadolinium enhancement. Patients were categorized into 4 subgroups based on presence and tertiles of scar extent: no scar, limited scar (scar burden 1% to 4%), intermediate scar (scar burden 5% to 20%), and extensive scar (scar burden >20%).
RESULTS
Among patients (n = 441) included in the study (age 59 ± 14 years, 43% with ischemic etiology), 85 (19%) experienced an adverse event. MRF ≥30% was associated with increased risk of events among the study group (hazard ratio: 1.74; 95% confidence interval: 1.10 to 2.76; p = 0.02). When stratified by presence or absence of scar, MRF ≥30% was associated with events only among patients with scar (hazard ratio: 1.67; 95% confidence interval: 1.02 to 2.76; p = 0.04) but not among patients without scar. On further classification of patients with scar, the prognostic significance of secondary MR was observed primarily among patients with intermediate scar burden.
CONCLUSIONS
The natural history of secondary MR is complex, and outcomes are affected by severity of MR and vary depending upon the extent of scar. (DeBakey Cardiovascular Magnetic Resonance Study [DEBAKEY-CMR]; NCT04281823).

Identifiants

pubmed: 33341417
pii: S1936-878X(20)31001-9
doi: 10.1016/j.jcmg.2020.11.004
pii:
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Banques de données

ClinicalTrials.gov
['NCT04281823']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

812-822

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Dr. Tayal has received grant support from Augustinus Fond and Regionnordjylland Forskningsfond. Dr. Shah has received salary support from the National Science Foundation (grants CNS-1646566 and CNS-1931884) and the National Institutes of Health (1R01HL137763-01). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Bhupendar Tayal (B)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA; Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark.

Dany Debs (D)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Faisal Nabi (F)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Maan Malahfji (M)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Stephen H Little (SH)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Michael Reardon (M)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

William Zoghbi (W)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Neal Kleiman (N)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA.

Dipan J Shah (DJ)

Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiovascular Imaging, Houston, Texas, USA. Electronic address: djshah@houstonmethodist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH